Don L. Henry FDA

Don Henry, Acting Director, Office of Program and Regulatory Operations (OPRO), OPQ, joined FDA in 2008 as a Regulatory Project Manager in the Office of New Drug Quality Assessment (now part of OPQ). He has also served as a Project Manager to facilitate the Quality by Design (QbD) program for the office, and as the Associate Director for Business Operations in OPRO. Prior to joining the FDA, Mr. Henry gained experienced working in industry managing validation, process development and scale-up activities. He is also currently serving as the acting Director in OPRO. Mr. Henry has a B.S. degree in mechanical engineering from the University of Delaware.